Form D · Pharmaceuticals
Concordia International Corp.
Mississauga, A6 · CIK 0001642271
Offering snapshot reported Sep 18, 2018 · SEC filing
- Reported sold
- $228M Offering amount: $587M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 6, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2018 | Initial | $228,028,553 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-321612
Of the total offering amount, $358,470,952.44 was sold pursuant to Regulation S.
Source: Form D, filed Sep 18, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Adeel Ahmad | Executive |
| Karl Belk | Executive |
| Randy Benson | Director |
| Paul Burden | Executive |
| Guy Clark | Executive |
| Douglas Deeth | Director |
| Graeme Duncan | Executive |
| Rochelle Fuhrmann | Director |
| Vikram Kamath | Executive |
| Itzhak Krinsky | Director |
| Francis I. Perier | Director |
| Robert Sully | Executive |
| Simon Tucker | Executive |
| Patrick Vink | Director |
| Jeridean Young | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
5770 Hurontario Street Suite 310
Mississauga, A6, L5R 3G5
Mississauga, A6, L5R 3G5